PrLZ regulates EMT and invasion in prostate cancer via the TGF‐β1/p‐smad2/miR‐200 family/ZEB1 axis
The Prostate · 2024
DOI: 10.1002/pros.24647 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Prostate, 2024. Verfasst von Hongjun Xie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: MicroRNAs, Prostatic Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Basic Research Plan in Shaanxi Province of China.
Abstract (Originalsprache)
Background
Prostate leucine zipper (PrLZ) is a prostate‐specific protein, and our previous study demonstrated that PrLZ enhances the malignant progression of prostate cancer (Pca). However, the roles of PrLZ in epithelial to mesenchymal transition (EMT) remain unknown.
Methods
Quantitative real‐time PCR (qRT‐PCR), immunohistochemical (IHC) staining, hematoxylin‐eosin (HE) staining, and western blotting were used to analyze the expression of protein and genes level in human PCa cell lines. Invasion assay was used to examine the effect of PrLZ, miR‐200a, miR‐200b, miR‐200c, miR‐141, miR‐429, miR‐205, and ZEB1 on PCa cell line invasion in vitro. Prostate cancer metastasis animal model was designed to assess the effect of PrLZ on PCa cell line invasion in vivo.
Results
We proved that high PrLZ expression initiates EMT, which was shown by the downregulation of E‐cadherin and upregulation of vimentin in PC‐3/PrLZ and ARCaP‐E/PrLZ cells. Mechanistic analysis revealed that PrLZ regulates EMT by activating TGF‐β1/p‐smad2 signaling and further inhibiting the expression of miR‐200 family members, which negatively regulates ZEB1 expression and causes EMT in Pca. Moreover, using two of orthotopic mouse model and tail vein injection of human prostate cancer cells mouse model, we observed that PC‐3/PrLZ cells led to the development of distant organ metastases in vivo.
Conclusions
Our results show the mechanism by which PrLZ regulates EMT and metastasis and suggest that PrLZ may be a potential therapeutic target for Pca metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
ORCID-Profile: Shan Xu
Förderung
- National Natural Science Foundation of China
- Natural Science Basic Research Plan in Shaanxi Province of China
Zitieren
APA
Xie, H., Chen, J., Ma, Z., Gao, Y., Zeng, J., Chen, Y., Yang, Z., & Xu, S. (2024). PrLZ regulates EMT and invasion in prostate cancer via the TGF‐β1/p‐smad2/miR‐200 family/ZEB1 axis. The Prostate. https://doi.org/10.1002/pros.24647
Vancouver
Xie H, Chen J, Ma Z, Gao Y, Zeng J, Chen Y, et al. PrLZ regulates EMT and invasion in prostate cancer via the TGF‐β1/p‐smad2/miR‐200 family/ZEB1 axis. The Prostate. 2024. doi:10.1002/pros.24647
BibTeX
@article{Xie2024,
author = {Xie, Hongjun and Chen, Jiaqi and Ma, Zhenkun and Gao, Yang and Zeng, Jin and Chen, Yule and Yang, Zhao and Xu, Shan},
title = {PrLZ regulates EMT and invasion in prostate cancer via the TGF‐β1/p‐smad2/miR‐200 family/ZEB1 axis},
journal = {The Prostate},
year = {2024},
doi = {10.1002/pros.24647}
}
EUVIMED